Increasing Walking and Bright Light Exposure to Improve Sleep in Community-Dwelling Persons with Alzheimer's Disease: Results of a Randomized, Controlled Trial

被引:156
|
作者
McCurry, Susan M. [1 ]
Pike, Kenneth C. [1 ]
Vitiello, Michael V. [2 ]
Logsdon, Rebecca G. [1 ]
Larson, Eric B. [3 ]
Teri, Linda [1 ]
机构
[1] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98115 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA
[3] Grp Hlth Res Inst, Seattle, WA USA
关键词
sleep; Alzheimer's disease; walking; light; adherence; NURSING-HOME RESIDENTS; PLACEBO-CONTROLLED TRIAL; INSTITUTIONALIZED PATIENTS; PHYSICAL-ACTIVITY; DEMENTIA; DISTURBANCES; PREDICTORS; MELATONIN; INSOMNIA; CAREGIVERS;
D O I
10.1111/j.1532-5415.2011.03519.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To test the effects of walking, light exposure, and a combination intervention (walking, light, and sleep education) on the sleep of persons with Alzheimer's disease (AD). DESIGN: Randomized, controlled trial with blinded assessors. SETTING: Independent community living. PARTICIPANTS: One hundred thirty-two people with AD and their in-home caregivers. INTERVENTIONS: Participants were randomly assigned to one of three active treatments (walking, light, combination treatment) or contact control and received three or six in-home visits. MEASUREMENTS: Primary outcomes were participant total wake time based on wrist actigraphy and caregiver ratings of participant sleep quality on the Sleep Disorders Inventory (SDI). Secondary sleep outcomes included additional actigraphic measurements of sleep percentage, number of awakenings, and total sleep time. RESULTS: Participants in walking (P = .05), light (P = .04), and combination treatment (P = .01) had significantly greater improvements in total wake time at posttest (effect size 0.51-0.63) than controls but no significant improvement on the SDI. Moderate effect size improvements in actigraphic sleep percentage were also observed in active treatment participants. There were no significant differences between the active treatment groups and no group differences for any sleep outcomes at 6 months. Participants with better adherence (4 d/wk) to walking and light exposure recommendations had significantly less total wake time (P = .006) and better sleep efficiency (P = .005) at posttest than those with poorer adherence. CONCLUSION: Walking, light exposure, and their combination are potentially effective treatments for improving sleep in community-dwelling persons with AD, but consistent adherence to treatment recommendations is required. J Am Geriatr Soc 59: 1393-1402, 2011.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [41] Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial
    Yang, Jie
    Hou, Liming
    Wang, Anhui
    Shang, Lei
    Jia, Xin
    Xu, Rong
    Wang, Xiaoming
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (18):
  • [42] A RANDOMIZED CONTROLLED ALZHEIMER'S DISEASE PREVENTION TRIAL'S EVOLUTION INTO AN EXPOSURE TRIAL: THE PREADVISE TRIAL
    Kryscio, R. J.
    Abner, E. L.
    Schmitt, F. A.
    Goodman, P. J.
    Mendiondo, M.
    Caban-Holt, A.
    Dennis, B. C.
    Mathews, M.
    Klein, E. A.
    Crowley, J. J.
    JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (01): : 72 - 75
  • [43] A randomized controlled Alzheimer’s disease prevention trial’s evolution into an exposure trial: The preadvise trial
    R. J. Kryscio
    E. L. Abner
    F. A. Schmitt
    P. J. Goodman
    M. Mendiondo
    A. Caban-Holt
    B. C. Dennis
    M. Mathews
    E. A. Klein
    J. J. Crowley
    The journal of nutrition, health & aging, 2013, 17 : 72 - 75
  • [44] Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease
    Kettunen, Reetta
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    Koponen, Marjaana
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (03) : 417 - 425
  • [45] Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
    Reetta Kettunen
    Heidi Taipale
    Anna-Maija Tolppanen
    Antti Tanskanen
    Jari Tiihonen
    Sirpa Hartikainen
    Marjaana Koponen
    European Journal of Clinical Pharmacology, 2019, 75 : 417 - 425
  • [46] Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study
    Laitinen, Marja-Liisa
    Lonnroos, Eija
    Bell, J. Simon
    Lavikainen, Piia
    Sulkava, Raimo
    Hartikainen, Sirpa
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (04) : 669 - 672
  • [47] Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease
    Hyttinen, Virva
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    Valtonen, Hannu
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (09) : 725 - 734
  • [48] Impact of the FindMyApps intervention on Social health in community-dwelling people with dementia: results from a randomized controlled trial
    Neal, David
    Ettema, Teake
    Dijkstra, Karin
    Graff, Maud
    Finnema, Evelyn
    Muller, Majon
    Droes, Rose-Marie
    INTERNATIONAL PSYCHOGERIATRICS, 2023, 35 : 113 - 114
  • [49] BrainWorks: A Comparative Effectiveness Trial to Examine Alzheimer's Disease Education for Community-Dwelling African Americans
    Lincoln, Karen D.
    Chow, Tiffany W.
    Gaines, Bryan F.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (01): : 53 - 61
  • [50] The effect of walking and vitamin B supplementation on quality of life in community-dwelling adults with mild cognitive impairment: a randomized, controlled trial
    Jannique G. Z. van Uffelen
    Marijke J. M. Chin A Paw
    Marijke Hopman-Rock
    Willem van Mechelen
    Quality of Life Research, 2007, 16 : 1137 - 1146